SI-BONE, Inc. (SIBN) Stock

SI-BONE, Inc., a pioneering medical device company, specializes in developing innovative implantable devices aimed at addressing musculoskeletal disorders affecting the sacropelvic anatomy. Operating both domestically and internationally, SI-BONE focuses on providing solutions for sacroiliac joint dysfunction and degeneration, adult deformity issues, and pelvic ring traumatic fractures.

Central to its product portfolio is the iFuse implant system, a minimally invasive surgical solution designed to stabilize and fuse the sacroiliac joint. This system effectively resolves pain and dysfunction associated with sacroiliac joint disorders. SI-BONE has further enhanced its offerings with iFuse-3D, featuring a titanium implant incorporating a unique 3D-printed porous surface and fenestrated design for improved osseointegration.

Additionally, SI-BONE introduces iFuse-TORQ, a set of 3D-printed threaded implants specifically engineered to treat pelvic fractures and facilitate minimally invasive sacroiliac joint fusion procedures. These advancements underscore the company's commitment to advancing surgical techniques and outcomes in the field of orthopedic and spine care.

Established in 2008 and headquartered in Santa Clara, California, SI-BONE markets its innovative devices primarily through a dedicated direct sales force and strategic distributor partnerships. With a focus on continuous innovation and clinical excellence, SI-BONE continues to expand its impact in improving patient outcomes and quality of life worldwide.